Status:
COMPLETED
Effect of S-ketamine in Cesarean Section Combined Anesthesia
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Conditions:
Postoperative Pain
Eligibility:
FEMALE
20-45 years
Phase:
PHASE4
Brief Summary
To compare the anti-hyperalgesia effect between S-ketamine with placebo for Maternal receiving elective Cesarean Section under Combined spinal and epidural analgesia. Based on this study the investig...
Eligibility Criteria
Inclusion
- ASA status I-III
- Age 20 to 45
- 37-42 weeks gestation
- undergo elective cesarean section with subarachnoid anesthesia
- participate in this study and sign informed consent
Exclusion
- Patients with contraindications for cesarean section
- Patients with contraindications of combined spinal and epidural anesthesia
- Patients with severe systemic disease
- Alcoholism and long-term use of anti-inflammatory and analgesic drugs
- Patients who were unable to cooperate or refused to participate in the trial
- Patients with contraindications to esketamine and hydromorphone
Key Trial Info
Start Date :
June 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05414006
Start Date
June 14 2022
End Date
September 5 2022
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400010